Probi AB (publ) logo

Probi AB (publ)

SSE:PROB.ST

Overview | Financials
Company Name Probi AB (publ)
Symbol PROB.ST
Currency SEK
Price 203
Market Cap 2,313,002,300
Dividend Yield 0.63%
52-week-range 165 - 216
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Anita Johansen
Website https://www.probi.com

An error occurred while fetching data.

About Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food

Related Stocks

Sedana Medical AB (publ) logo

Sedana Medical AB (publ)

SEDANA.ST

16.85 SEK

Genovis AB (publ.) logo

Genovis AB (publ.)

GENO.ST

43.5 SEK

Bonesupport Holding AB (publ) logo

Bonesupport Holding AB (publ)

BONEX.ST

189.8 SEK

Bactiguard Holding AB (publ) logo

Bactiguard Holding AB (publ)

BACTI-B.ST

84.4 SEK

Attendo AB (publ) logo

Attendo AB (publ)

ATT.ST

37.8 SEK

Hansa Biopharma AB (publ) logo

Hansa Biopharma AB (publ)

HNSA.ST

32.64 SEK

BioInvent International AB (publ) logo

BioInvent International AB (publ)

BINV.ST

16.58 SEK

Q-linea AB (publ) logo

Q-linea AB (publ)

QLINEA.ST

2.49 SEK

Ambea AB (publ) logo

Ambea AB (publ)

AMBEA.ST

57.2 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD